Application of chromosomal microarray analysis for fetuses with talipes equinovarus
10.3760/cma.j.issn.0529-567x.2016.07.002
- VernacularTitle:染色体微阵列分析技术在马蹄足内翻胎儿产前诊断中的应用
- Author:
Qiaoli GUO
;
Fang FU
;
Ru LI
;
Xiangyi JING
;
Tingying LEI
;
Jin HAN
;
Xin YANG
;
Li ZHEN
;
Min PAN
;
Can LIAO
- Publication Type:Journal Article
- Keywords:
Clubfoot;
Chromosomes,human;
Microarray analysis;
Ultrasonography,prenatal;
DNA copy number variations;
Karyotyping
- From:
Chinese Journal of Obstetrics and Gynecology
2016;51(7):484-490
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the application of fetuses with talipes equinovarus (TE) using chromosomal microarray analysis (CMA) technology. Methods From May 2012 to June 2015, 54 fetuses were found with TE and with or without other structural anomalies by prenatal ultrasound. Karyotyping was taking for them all, and the fetuses with normal karyotypes took another CMA test. The data were analyzed with CHAS software. Finally all the cases were followed up to know about their pregnancy outcomes. Results One of the 54 cases was detected with abnormal karyotype which was trisomy 18 (2%, 1/54). CMA was undertaken to the remaining fetuses, they were divided into 2 groups, including isolated TE group (n=38) and complex TE group (n=15). The detection rate of clinical significant copy number variations (CNV) by CMA was 11% (6/53), while isolated and complex TE group were 5% (2/38) and 4/15, respectively (P=0.047). Of the 53 cases, 51 cases were successfully followed up. Eleven cases were found without TE after birth, and the false positive rate (FPR) of TE was 22%(11/51). Conclusions Whole-genome high-resolution CMA increased the detection rate by 11% in fetuses with TE. With the FPR and the detection rate of the clinical significant CNV of 2 groups, whole-genome CMA could be recommended to the fetuses with complex TE group but normal karyotypes. A series of ultrasonic tests should be suggested to the isolate TE group, while with the abnormal ultrasound, fetuses would be suggested to have CMA test for decreasing the rates of invasive prenatal diagnosis and FPR.
